Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Galit Denkberg

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Autoimmunity Reviews|May 16, 2006
Recombinant antibodies with T-cell receptor-like specificity: novel tools to study MHC class I presentationGalit Denkberg, Yoram Reiter
Journal of Immunology (Baltimore, Md. : 1950)|October 9, 2002
Modification of a tumor-derived peptide at an HLA-A2 anchor residue can alter the conformation of the MHC-peptide complex: probing with TCR-like recombinant antibodiesGalit Denkberg, Eynav Klechevsky, Yoram Reiter
Journal of Immunology (Baltimore, Md. : 1950)|August 21, 2003
Selective targeting of melanoma and APCs using a recombinant antibody with TCR-like specificity directed toward a melanoma differentiation antigenGalit Denkberg, Avital Lev, Lea Eisenbach, et al.
Journal of Molecular Recognition : JMR|October 3, 2003
Recombinant antibodies with MHC-restricted, peptide-specific, T-cell receptor-like specificity: new tools to study antigen presentation and TCR-peptide-MHC interactionsCyril J Cohen, Galit Denkberg, Avital Lev, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 3, 2002
Direct visualization of distinct T cell epitopes derived from a melanoma tumor-associated antigen by using human recombinant antibodies with MHC- restricted T cell receptor-like specificityGalit Denkberg, Cyril J Cohen, Avital Lev, et al.
Cancer Research|August 5, 2008
Antitumor activity of immunotoxins with T-cell receptor-like specificity against human melanoma xenograftsEynav Klechevsky, Michael Gallegos, Galit Denkberg, et al.
Journal of Immunological Methods|June 12, 2003
Simultaneous monitoring of binding to and activation of tumor-specific T lymphocytes by peptide-MHCCyril J Cohen, Galit Denkberg, Yael S Schiffenbauer, et al.
Expert Review of Anticancer Therapy|October 28, 2005
T-cell receptor-like antibodies: novel reagents for clinical cancer immunology and immunotherapyRoy Noy, Malka Eppel, Maya Haus-Cohen, et al.
Cancer Research|April 6, 2006
The influence of a human embryonic stem cell-derived microenvironment on targeting of human solid tumor xenograftsMaty Tzukerman, Tzur Rosenberg, Irena Reiter, et al.
Analytical Biochemistry|July 14, 2010
Therapeutic antibodies: Discovery and development using the ProteOn XPR36 biosensor interaction array systemVered Bronner, Galit Denkberg, Mira Peled, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Autoimmunity Reviews|May 16, 2006
Recombinant antibodies with T-cell receptor-like specificity: novel tools to study MHC class I presentationGalit Denkberg, Yoram Reiter
Journal of Immunology (Baltimore, Md. : 1950)|October 9, 2002
Modification of a tumor-derived peptide at an HLA-A2 anchor residue can alter the conformation of the MHC-peptide complex: probing with TCR-like recombinant antibodiesGalit Denkberg, Eynav Klechevsky, Yoram Reiter
Journal of Immunology (Baltimore, Md. : 1950)|August 21, 2003
Selective targeting of melanoma and APCs using a recombinant antibody with TCR-like specificity directed toward a melanoma differentiation antigenGalit Denkberg, Avital Lev, Lea Eisenbach, et al.
Journal of Molecular Recognition : JMR|October 3, 2003
Recombinant antibodies with MHC-restricted, peptide-specific, T-cell receptor-like specificity: new tools to study antigen presentation and TCR-peptide-MHC interactionsCyril J Cohen, Galit Denkberg, Avital Lev, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 3, 2002
Direct visualization of distinct T cell epitopes derived from a melanoma tumor-associated antigen by using human recombinant antibodies with MHC- restricted T cell receptor-like specificityGalit Denkberg, Cyril J Cohen, Avital Lev, et al.
Cancer Research|August 5, 2008
Antitumor activity of immunotoxins with T-cell receptor-like specificity against human melanoma xenograftsEynav Klechevsky, Michael Gallegos, Galit Denkberg, et al.
Journal of Immunological Methods|June 12, 2003
Simultaneous monitoring of binding to and activation of tumor-specific T lymphocytes by peptide-MHCCyril J Cohen, Galit Denkberg, Yael S Schiffenbauer, et al.
Expert Review of Anticancer Therapy|October 28, 2005
T-cell receptor-like antibodies: novel reagents for clinical cancer immunology and immunotherapyRoy Noy, Malka Eppel, Maya Haus-Cohen, et al.
Cancer Research|April 6, 2006
The influence of a human embryonic stem cell-derived microenvironment on targeting of human solid tumor xenograftsMaty Tzukerman, Tzur Rosenberg, Irena Reiter, et al.
Analytical Biochemistry|July 14, 2010
Therapeutic antibodies: Discovery and development using the ProteOn XPR36 biosensor interaction array systemVered Bronner, Galit Denkberg, Mira Peled, et al.
Pageof 2